Amylyx Pharmaceuticals
AMLX
$2.06
Share price
3.25%
Change (1 day)
-92.57%
Change (1 year)
Categories
Revenue for Amylyx Pharmaceuticals (AMLX)
Revenue in 2023 (TTM): $0.38 B
According to Amylyx Pharmaceuticals's latest financial reports the company's current revenue (TTM
) is $0.38 B.
In 2022 the company made a revenue of $22.23 M an increase over the years 2021 revenue that were of N/A.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Amylyx Pharmaceuticals from 2021 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $0.38 B | 1612.94% |
| 2022 | $22.23 M | |
| 2021 | N/A |